Giulia Quaresmini

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 275 citations · Full text

Medicine, Hematology, Internal Medicine +10

Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution

Chiara Cattaneo, Giulia Quaresmini, Salvatore Casari et al. · Journal of Antimicrobial Chemotherapy · 2008 · 153 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Deferasirox for transfusion‐dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (<scp>GIMEMA MDS</scp>0306 <scp>T</scp>rial)

Emanuele Angelucci, Valeria Santini, Anna Angela Di Tucci et al. · European Journal Of Haematology · 2014 · 95 citations · Full text

Medicine, Hematology, Pharmacology +17

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial

Alessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci et al. · The Lancet Oncology · 2024 · 33 citations

Medicine, Hematology, Oncology +14